Cancer evolution and individual susceptibility

Integrative Biology

Volumn 3, Issue 4, 2011, Pages 316-328

  Pérez Losada, Jesús ^a   Castellanos Martín, Andrés ^a   Mao, Jian Hua ^b  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; APOPTOSIS; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CELL COMPARTMENTALIZATION; CELL PROLIFERATION; DNA REPAIR; GENE EXPRESSION; GENE INTERACTION; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; IMMUNE SYSTEM; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; STROMA; TUMOR CELL;

ANIMALS; DISEASE SUSCEPTIBILITY; ENVIRONMENTAL EXPOSURE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; NEOPLASMS; QUANTITATIVE TRAIT LOCI;

EID: 79953757667     PISSN: 17579694     EISSN: 17579708     Source Type: Journal    
DOI: 10.1039/c0ib00094a     Document Type: Review

References (117)

1. A. Carmichael, A. S. Sami and J. M. Dixon, Breast cancer risk among the survivors of atomic bomb and patients exposed to therapeutic ionising radiation, Eur. J. Surg. Oncol., 2003, 29, 475-9.
2. J. A. Aguirre-Ghiso, Models, mechanisms and clinical evidence for cancer dormancy, Nat. Rev. Cancer, 2007, 7, 834-46.
3. D. J. Slamon, B. Leyland-Jones, S. Shak, H. Fuchs, V. Paton, A. Bajamonde, T. Fleming, W. Eiermann, J. Wolter, M. Pegram, J. Baselga and L. Norton, Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2, N. Engl. J. Med., 2001, 344, 783-92.
4. C. Smigal, A. Jemal, E. Ward, V. Cokkinides, R. Smith, H. L. Howe and M. Thun, Trends in breast cancer by race and ethnicity: update 2006, Ca-Cancer J. Clin., 2006, 56, 168-83.
5. S. F. Winter and K. W. Hunter, Mouse modifier genes in mammary tumorigenesis and metastasis, J. Mammary Gland Biol. Neoplasia, 2008, 13, 337-42.
6. A. Balmain, Cancer as a complex genetic trait: tumor susceptibility in humans and mouse models, Cell, 2002, 108, 145-52. (Pubitemid 34161135)
7. L. M. Coussens and Z. Werb, Inflammation and cancer, Nature, 2002, 420, 860-7. (Pubitemid 36019639)
8. K. W. Hunter and N. P. Crawford, The future of mouse QTL mapping to diagnose disease in mice in the age of whole-genome association studies, Annu. Rev. Genet., 2008, 42, 131-41.
9. T. Walsh and M. C. King, Ten genes for inherited breast cancer, Cancer Cell, 2007, 11, 103-5.
10. J. McClellan and M. C. King, Genetic heterogeneity in human disease, Cell, 2010, 141, 210-7.
11. P. Lichtenstein, N. V. Holm, P. K. Verkasalo, A. Iliadou, J. Kaprio, M. Koskenvuo, E. Pukkala, A. Skytthe and K. Hemminki, Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland, N. Engl. J. Med., 2000, 343, 78-85.
12. K. Czene, P. Lichtenstein and K. Hemminki, Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database, Int. J. Cancer, 2002, 99, 260-6. (Pubitemid 34309484)
13. I. B. Borecki and M. A. Province, Linkage and association: basic concepts, Adv. Genet., 2008, 60, 51-74.
14. F. H. Fodor, A. Weston, I. J. Bleiweiss, L. D. McCurdy, M. M. Walsh, P. I. Tartter, S. T. Brower and C. M. Eng, Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients, Am. J. Hum. Genet., 1998, 63, 45-51.
15. K. L. Nathanson, R. Wooster and B. L. Weber, Breast cancer genetics: what we know and what we need, Nat. Med., 2001, 7, 552-6. (Pubitemid 32448321)
16. A. Galvan, J. P. Ioannidis and T. A. Dragani, Beyond genome-wide association studies: genetic heterogeneity and individual predisposition to cancer, Trends Genet., 2010, 26, 132-41.
17. A. A. Donjacour and G. R. Cunha, Stromal regulation of epithelial function, Cancer Treat Res., 1991, 53, 335-64.
18. R. Paus, E. M. Peters, S. Eichmuller and V. A. Botchkarev, Neural mechanisms of hair growth control, J. Investig. Dermatol. Symp. Proc., 1997, 2, 61-8.
19. J. Perez-Losada and A. Balmain, Stem-cell hierarchy in skin cancer, Nat. Rev. Cancer, 2003, 3, 434-43. (Pubitemid 37328847)
20. H. F. Dvorak, Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing, N. Engl. J. Med., 1986, 315, 1650-9.
21. A. F. Olumi, G. D. Grossfeld, S. W. Hayward, P. R. Carroll, T. D. Tlsty and G. R. Cunha, Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium, Cancer Res., 1999, 59, 5002-11.
22. K. Kurose, K. Gilley, S. Matsumoto, P. H. Watson, X. P. Zhou and C. Eng, Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas, Nat. Genet., 2002, 32, 355-7. (Pubitemid 35266108)
23. V. M. Weaver and P. Gilbert, Watch thy neighbor: cancer is a communal affair, J. Cell Sci., 2004, 117, 1287-90.
24. A. J. Trimboli, C. Z. Cantemir-Stone, F. Li, J. A. Wallace, A. Merchant, N. Creasap, J. C. Thompson, E. Caserta, H. Wang, J. L. Chong, S. Naidu, G. Wei, S. M. Sharma, J. A. Stephens, S. A. Fernandez, M. N. Gurcan, M. B. Weinstein, S. H. Barsky, L. Yee, T. J. Rosol, P. C. Stromberg, M. L. Robinson, F. Pepin, M. Hallett, M. Park, M. C. Ostrowski and G. Leone, Pten in stromal fibroblasts suppresses mammary epithelial tumours, Nature, 2009, 461, 1084-91.
25. J. A. Joyce and J. W. Pollard, Microenvironmental regulation of metastasis, Nat. Rev. Cancer, 2009, 9, 239-52.
26. B. Qian, Y. Deng, J. H. Im, R. J. Muschel, Y. Zou, J. Li, R. A. Lang and J. W. Pollard, A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth, PLoS One, 2009, 4, e6562.
27. B. Z. Qian and J. W. Pollard, Macrophage diversity enhances tumor progression and metastasis, Cell, 2010, 141, 39-51.
28. D. G. DeNardo, P. Andreu and L. M. Coussens, Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity, Cancer Metastasis Rev., 2010, 29, 309-16.
29. K. Kessenbrock, V. Plaks and Z. Werb, Matrix metalloproteinases: regulators of the tumor microenvironment, Cell, 2010, 141, 52-67.
30. N. Bellam and B. Pasche, Tgf-beta signaling alterations and colon cancer, Cancer Treat. Res., 2010, 155, 85-103.
31. M. MacPhee, K. P. Chepenik, R. A. Liddell, K. K. Nelson, L. D. Siracusa and A. M. Buchberg, The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia, Cell, 1995, 81, 957-66.
32. W. Pruzanski and P. Vadas, Phospholipase A2-a mediator between proximal and distal effectors of inflammation, Immunol. Today, 1991, 12, 143-6.
33. W. Jaross, R. Eckey and M. Menschikowski, Biological effects of secretory phospholipase A(2) group IIA on lipoproteins and in atherogenesis, Eur. J. Clin. Invest., 2002, 32, 383-93.
34. S. Y. Leung, X. Chen, K. M. Chu, S. T. Yuen, J. Mathy, J. Ji, A. S. Chan, R. Li, S. Law, O. G. Troyanskaya, I. P. Tu, J. Wong, S. So, D. Botstein and P. O. Brown, Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis, Proc. Natl. Acad. Sci. U. S. A., 2002, 99, 16203-8.
35. M. R. Stratton and N. Rahman, The emerging landscape of breast cancer susceptibility, Nat. Genet., 2008, 40, 17-22.
36. J. C. Barrett, S. Hansoul, D. L. Nicolae, J. H. Cho, R. H. Duerr, J. D. Rioux, S. R. Brant, M. S. Silverberg, K. D. Taylor, M. M. Barmada, A. Bitton, T. Dassopoulos, L. W. Datta, T. Green, A. M. Griffiths, E. O. Kistner, M. T. Murtha, M. D. Regueiro, J. I. Rotter, L. P. Schumm, A. H. Steinhart, S. R. Targan, R. J. Xavier, C. Libioulle, C. Sandor, M. Lathrop, J. Belaiche, O. Dewit, I. Gut, S. Heath, D. Laukens, M. Mni, P. Rutgeerts, A. Van Gossum, D. Zelenika, D. Franchimont, J. P. Hugot, M. de Vos, S. Vermeire, E. Louis, L. R. Cardon, C. A. Anderson, H. Drummond, E. Nimmo, T. Ahmad, N. J. Prescott, C. M. Onnie, S. A. Fisher, J. Marchini, J. Ghori, S. Bumpstead, R. Gwilliam, M. Tremelling, P. Deloukas, J. Mansfield, D. Jewell, J. Satsangi, C. G. Mathew, M. Parkes, M. Georges and M. J. Daly, Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease, Nat. Genet., 2008, 40, 955-62.
37. P. J. Wysocki and B. Wierusz-Wysocka, Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin, Expert Rev. Mol. Diagn., 2010, 10, 509-19.
38. P. Tai, E. Yu, K. Joseph and T. Miale, A review of autoimmune diseases associated with cancer, Frontiers in Bioscience, 2010, 2, 122-6.
39. A. A. Siddiqui, Metabolic Syndrome and Its Association With Colorectal Cancer: A Review, Am. J. Med. Sci., 2010.
40. I. Goh, M. E. Cusick, D. Valle, B. Childs, M. Vidal and A. L. Barabasi, The human disease network, Proc. Natl. Acad. Sci. U. S. A., 2007, 104, 8685-90.
41. N. Risch and K. Merikangas, The future of genetic studies of complex human diseases, Science, 1996, 273, 1516-7. (Pubitemid 26301653)
42. H. Meijers-Heijboer, A. van den Ouweland, J. Klijn, M. Wasielewski, A. de Snoo, R. Oldenburg, A. Hollestelle, M. Houben, E. Crepin, M. van Veghel-Plandsoen, F. Elstrodt, C. van Duijn, C. Bartels, C. Meijers, M. Schutte, L. McGuffog, D. Thompson, D. Easton, N. Sodha, S. Seal, R. Barfoot, J. Mangion, J. Chang-Claude, D. Eccles, R. Eeles, D. G. Evans, R. Houlston, V. Murday, S. Narod, T. Peretz, J. Peto, C. Phelan, H. X. Zhang, C. Szabo, P. Devilee, D. Goldgar, P. A. Futreal, K. L. Nathanson, B. Weber, N. Rahman and M. R. Stratton, Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations, Nat. Genet., 2002, 31, 55-9.
43. J. M. Rosa-Rosa, G. Pita, M. Urioste, G. Llort, J. Brunet, C. Lazaro, I. Blanco, T. Ramon y Cajal, O. Diez, M. de la Hoya, T. Caldes, M. I. Tejada, A. Gonzalez-Neira and J. Benitez, Genome-wide linkage scan reveals three putative breast-cancer-susceptibility loci, Am. J. Hum. Genet., 2009, 84, 115-22.
44. D. F. Easton, K. A. Pooley, A. M. Dunning, P. D. Pharoah, D. Thompson, D. G. Ballinger, J. P. Struewing and J. Morrison, et al., Genome-wide association study identifies novel breast cancer susceptibility loci, Nature, 2007, 447, 1087-93. (Pubitemid 47014426)
45. S. N. Stacey, A. Manolescu, P. Sulem, T. Rafnar, J. Gudmundsson, S. A. Gudjonsson, G. Masson, M. Jakobsdottir, S. Thorlacius, A. Helgason, K. K. Aben, L. J. Strobbe, M. T. Albers-Akkers, D. W. Swinkels, B. E. Henderson, L. N. Kolonel, L. Le Marchand, E. Millastre, R. Andres, J. Godino, M. D. Garcia-Prats, E. Polo, A. Tres, M. Mouy, J. Saemundsdottir, V. M. Backman, L. Gudmundsson, K. Kristjansson, J. T. Bergthorsson, J. Kostic, M. L. Frigge, F. Geller, D. Gudbjartsson, H. Sigurdsson, T. Jonsdottir, J. Hrafnkelsson, J. Johannsson, T. Sveinsson, G. Myrdal, H. N. Grimsson, T. Jonsson, S. von Holst, B. Werelius, S. Margolin, A. Lindblom, J. I. Mayordomo, C. A. Haiman, L. A. Kiemeney, O. T. Johannsson, J. R. Gulcher, U. Thorsteinsdottir, A. Kong and K. Stefansson, Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer, Nat. Genet., 2007, 39, 865-9.
46. J. M. Murabito, C. L. Rosenberg, D. Finger, B. E. Kreger, D. Levy, G. L. Splansky, K. Antman and S. J. Hwang, A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study, BMC Medical Genetics, 2007, 8(Suppl 1), S6.
47. D. J. Hunter, P. Kraft, K. B. Jacobs, D. G. Cox, M. Yeager, S. E. Hankinson, S. Wacholder, Z. Wang, R. Welch, A. Hutchinson, J. Wang, K. Yu, N. Chatterjee, N. Orr, W. C. Willett, G. A. Colditz, R. G. Ziegler, C. D. Berg, S. S. Buys, C. A. McCarty, H. S. Feigelson, E. E. Calle, M. J. Thun, R. B. Hayes, M. Tucker, D. S. Gerhard, J. F. Fraumeni, Jr., R. N. Hoover, G. Thomas and S. J. Chanock, A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer, Nat. Genet., 2007, 39, 870-4. (Pubitemid 47014500)
48. B. Gold, T. Kirchhoff, S. Stefanov, J. Lautenberger, A. Viale, J. Garber, E. Friedman, S. Narod, A. B. Olshen, P. Gregersen, K. Kosarin, A. Olsh, J. Bergeron, N. A. Ellis, R. J. Klein, A. G. Clark, L. Norton, M. Dean, J. Boyd and K. Offit, Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33, Proc. Natl. Acad. Sci. U. S. A., 2008, 105, 4340-5.
49. W. Zheng, J. Long, Y. T. Gao, C. Li, Y. Zheng, Y. B. Xiang, W. Wen, S. Levy, S. L. Deming, J. L. Haines, K. Gu, A. M. Fair, Q. Cai, W. Lu and X. O. Shu, Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1, Nat. Genet., 2009, 41, 324-8.
50. G. Thomas, K. B. Jacobs, P. Kraft, M. Yeager, S. Wacholder, D. G. Cox, S. E. Hankinson, A. Hutchinson, Z. Wang, K. Yu, N. Chatterjee, M. Garcia-Closas, J. Gonzalez-Bosquet, L. Prokunina-Olsson, N. Orr, W. C. Willett, G. A. Colditz, R. G. Ziegler, C. D. Berg, S. S. Buys, C. A. McCarty, H. S. Feigelson, E. E. Calle, M. J. Thun, R. Diver, R. Prentice, R. Jackson, C. Kooperberg, R. Chlebowski, J. Lissowska, B. Peplonska, L. A. Brinton, A. Sigurdson, M. Doody, P. Bhatti, B. H. Alexander, J. Buring, I. M. Lee, L. J. Vatten, K. Hveem, M. Kumle, R. B. Hayes, M. Tucker, D. S. Gerhard, J. F. Fraumeni, Jr., R. N. Hoover, S. J. Chanock and D. J. Hunter, A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1), Nat. Genet., 2009, 41, 579-84.
51. S. Ahmed, G. Thomas, M. Ghoussaini, C. S. Healey, M. K. Humphreys, R. Platte, J. Morrison and M. Maranian, et al., Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2, Nat. Genet., 2009, 41, 585-90.
52. S. N. Stacey, A. Manolescu, P. Sulem, S. Thorlacius, S. A. Gudjonsson, G. F. Jonsson, M. Jakobsdottir, J. T. Bergthorsson, J. Gudmundsson, K. K. Aben, L. J. Strobbe, D. W. Swinkels, K. C. van Engelenburg, B. E. Henderson, L. N. Kolonel, L. Le Marchand, E. Millastre, R. Andres, B. Saez, J. Lambea, J. Godino, E. Polo, A. Tres, S. Picelli, J. Rantala, S. Margolin, T. Jonsson, H. Sigurdsson, T. Jonsdottir, J. Hrafnkelsson, J. Johannsson, T. Sveinsson, G. Myrdal, H. N. Grimsson, S. G. Sveinsdottir, K. Alexiusdottir, J. Saemundsdottir, A. Sigurdsson, J. Kostic, L. Gudmundsson, K. Kristjansson, G. Masson, J. D. Fackenthal, C. Adebamowo, T. Ogundiran, O. I. Olopade, C. A. Haiman, A. Lindblom, J. I. Mayordomo, L. A. Kiemeney, J. R. Gulcher, T. Rafnar, U. Thorsteinsdottir, O. T. Johannsson, A. Kong and K. Stefansson, Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer, Nat. Genet., 2008, 40, 703-6. (Pubitemid 351748861)
53. R. L. Milne, J. Benitez, H. Nevanlinna, T. Heikkinen, K. Aittomaki, C. Blomqvist, J. I. Arias, M. P. Zamora, B. Burwinkel, C. R. Bartram, A. Meindl, R. K. Schmutzler, A. Cox, I. Brock, G. Elliott, M. W. Reed, M. C. Southey, L. Smith, A. B. Spurdle, J. L. Hopper, F. J. Couch, J. E. Olson, X. Wang, Z. Fredericksen, P. Schurmann, M. Bremer, P. Hillemanns, T. Dork, P. Devilee, C. J. van Asperen, R. A. Tollenaar, C. Seynaeve, P. Hall, K. Czene, J. Liu, Y. Li, S. Ahmed, A. M. Dunning, M. Maranian, P. D. Pharoah, G. Chenevix-Trench, J. Beesley, N. V. Bogdanova, N. N. Antonenkova, I. V. Zalutsky, H. Anton-Culver, A. Ziogas, H. Brauch, C. Justenhoven, Y. D. Ko, S. Haas, P. A. Fasching, R. Strick, A. B. Ekici, M. W. Beckmann, G. G. Giles, G. Severi, L. Baglietto, D. R. English, O. Fletcher, N. Johnson, I. dos Santos Silva, J. Peto, C. Turnbull, S. Hines, A. Renwick, N. Rahman, B. G. Nordestgaard, S. E. Bojesen, H. Flyger, D. Kang, K. Y. Yoo, D. Y. Noh, A. Mannermaa, V. Kataja, V. M. Kosma, M. Garcia-Closas, S. Chanock, J. Lissowska, L. A. Brinton, J. Chang-Claude, S. Wang-Gohrke, C. Y. Shen, H. C. Wang, J. C. Yu, S. T. Chen, M. Bermisheva, T. Nikolaeva, E. Khusnutdinova, M. K. Humphreys, J. Morrison, R. Platte and D. F. Easton, Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042, J. Natl. Cancer Inst., 2009, 101, 1012-8.
54. P. Boyle, P. Boffetta and P. Autier, Diet, nutrition and cancer: public, media and scientific confusion, Ann. Oncol., 2008, 19, 1665-7.
55. R. C. Travis, G. K. Reeves, J. Green, D. Bull, S. J. Tipper, K. Baker, V. Beral, R. Peto, J. Bell, D. Zelenika and M. Lathrop, Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study, Lancet, 2010, 375, 2143-51.
56. C. J. Hoggart, T. G. Clark, M. De Iorio, J. C. Whittaker and D. J. Balding, Genome-wide significance for dense SNP and resequencing data, Mol. Genet. Epidemiol., 2008, 32, 179-85.
57. J. P. Ioannidis, E. E. Ntzani, T. A. Trikalinos and D. G. Contopoulos-Ioannidis, Replication validity of genetic association studies, Nat. Genet., 2001, 29, 306-9. (Pubitemid 33096456)
58. M. J. Khoury, L. Bertram, P. Boffetta, A. S. Butterworth, S. J. Chanock, S. M. Dolan, I. Fortier, M. Garcia-Closas, M. Gwinn, J. P. Higgins, A. C. Janssens, J. Ostell, R. P. Owen, R. A. Pagon, T. R. Rebbeck, N. Rothman, J. L. Bernstein, P. R. Burton, H. Campbell, A. Chockalingam, H. Furberg, J. Little, T. R. O'Brien, D. Seminara, P. Vineis, D. M. Winn, W. Yu and J. P. Ioannidis, Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases, American Journal of Epidemiology, 2009, 170, 269-79.
59. J. P. Ioannidis, Calibration of credibility of agnostic genome-wide associations, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2008, 147B, 964-72.
60. J. P. Ioannidis, E. Y. Loy, R. Poulton and K. S. Chia, Researching genetic versus nongenetic determinants of disease: a comparison and proposed unification, Sci. Transl.Med., 2009, 1, 7ps8.
61. E. Linos and W. C. Willett, Diet and breast cancer risk reduction, J. Natl. Compr. Canc. Netw., 2007, 5, 711-718.
62. K. Britt, A. Ashworth and M. Smalley, Pregnancy and the risk of breast cancer, Endocr. Relat. Cancer, 2007, 14, 907-33. (Pubitemid 351252427)
63. A. Schatzkin and M. P. Longnecker, Alcohol and breast cancer. Where are we now and where do we go from here?, Cancer, 1994, 74, 1101-10.
64. C. B. Ambrosone, The promise and limitations of genome-wide association studies to elucidate the causes of breast cancer, Breast Cancer Res., 2007, 9, 114.
65. E. A. Ostrander and J. L. Stanford, Genetics of prostate cancer: too many loci, too few genes, Am. J. Hum. Genet., 2000, 67, 1367-75.
66. P. A. Futreal, Q. Liu, D. Shattuck-Eidens, C. Cochran, K. Harshman, S. Tavtigian, L. M. Bennett, A. Haugen-Strano, J. Swensen and Y. Miki, et al., BRCA1 mutations in primary breast and ovarian carcinomas, Science, 1994, 266, 120-2. (Pubitemid 24345332)
67. R. A. Oldenburg, K. Kroeze-Jansema, J. Kraan, H. Morreau, J. G. Klijn, N. Hoogerbrugge, M. J. Ligtenberg, C. J. van Asperen, H. F. Vasen, C. Meijers, H. Meijers-Heijboer, T. H. de Bock, C. J. Cornelisse and P. Devilee, The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families, Cancer Res., 2003, 63, 8153-7. (Pubitemid 37549462)
68. S. Wang-Gohrke, T. R. Rebbeck, W. Besenfelder, R. Kreienberg and I. B. Runnebaum, p53 germline polymorphisms are associated with an increased risk for breast cancer in German women, Anticancer Res., 1998, 18, 2095-9.
69. R. Wooster, G. Bignell, J. Lancaster, S. Swift, S. Seal, J. Mangion, N. Collins, S. Gregory, C. Gumbs and G. Micklem, Identification of the breast cancer susceptibility gene BRCA2, Nature, 1995, 378, 789-92. (Pubitemid 26004412)
70. T. van Wezel, A. P. Stassen, C. J. Moen, A. A. Hart, M. A. van der Valk and P. Demant, Gene interaction and single gene effects in colon tumour susceptibility in mice, Nat. Genet., 1996, 14, 468-70. (Pubitemid 26414593)
71. R. J. Fijneman, R. C. Jansen, M. A. van der Valk and P. Demant, High frequency of interactions between lung cancer susceptibility genes in the mouse: mapping of Sluc5 to Sluc14, Cancer Res., 1998, 58, 4794-8. (Pubitemid 28503670)
72. T. F. Mackay, Quantitative trait loci in Drosophila, Nature Reviews Genetics, 2001, 2, 11-20.
73. H. Nagase, J. H. Mao, J. P. de Koning, T. Minami and A. Balmain, Epistatic interactions between skin tumor modifier loci in interspecific (spretus/musculus) backcross mice, Cancer Res., 2001, 61, 1305-8. (Pubitemid 34292547)
74. D. A. Quigley, M. D. To, J. Perez-Losada, F. G. Pelorosso, J. H. Mao, H. Nagase, D. G. Ginzinger and A. Balmain, Genetic architecture of mouse skin inflammation and tumour susceptibility, Nature, 2009, 458, 505-8.
75. D. Quigley and A. Balmain, Systems genetics analysis of cancer susceptibility: from mouse models to humans, Nat. Rev. Genet., 2009, 10, 651-7.
76. A. Balmain and H. Nagase, Cancer resistance genes in mice: models for the study of tumour modifiers, Trends Genet., 1998, 14, 139-44. (Pubitemid 28206393)
77. J. H. Nadeau and W. N. Frankel, The roads from phenotypic variation to gene discovery: mutagenesis versus QTLs, Nat. Genet., 2000, 25, 381-4. (Pubitemid 32983426)
78. A. Matin, G. B. Collin, Y. Asada, D. Varnum and J. H. Nadeau, Susceptibility to testicular germ-cell tumours in a 129.MOLF-Chr 19 chromosome substitution strain, Nat. Genet., 1999, 23, 237-40. (Pubitemid 29455401)
79. F. S. Collins, R. H. Finnell, J. Rossant and W. Wurst, A new partner for the international knockout mouse consortium, Cell, 2007, 129, 235. (Pubitemid 46574983)
80. A. Darvasi, Dissecting complex traits: the geneticists' "Around the world in 80 days", Trends Genet., 2005, 21, 373-6.
81. M. D. To, J. Perez-Losada, J. H. Mao, J. Hsu, T. Jacks and A. Balmain, A functional switch from lung cancer resistance to susceptibility at the Pas1 locus in Kras2LA2 mice, Nat. Genet., 2006, 38, 926-30. (Pubitemid 44141662)
82. A. Balmain and C. C. Harris, Carcinogenesis in mouse and human cells: parallels and paradoxes, Carcinogenesis, 2000, 21, 371-7.
83. X. Wang and B. Paigen, Genetics of variation in HDL cholesterol in humans and mice, Circ. Res., 2005, 96, 27-42. (Pubitemid 40095752)
84. N. P. Crawford, X. Qian, A. Ziogas, A. G. Papageorge, B. J. Boersma, R. C. Walker, L. Lukes, W. L. Rowe, J. Zhang, S. Ambs, D. R. Lowy, H. Anton-Culver and K. W. Hunter, Rrp1b, a new candidate susceptibility gene for breast cancer progression and metastasis, PLoS Genet., 2007, 3, e214.
85. N. P. Crawford, A. Ziogas, D. J. Peel, J. Hess, H. Anton-Culver and K. W. Hunter, Germline polymorphisms in SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancer, Breast Cancer Res., 2006, 8, R16.
86. A. Ewart-Toland, P. Briassouli, J. P. de Koning, J. H. Mao, J. Yuan, F. Chan, L. MacCarthy-Morrogh, B. A. Ponder, H. Nagase, J. Burn, S. Ball, M. Almeida, S. Linardopoulos and A. Balmain, Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human, Nat. Genet., 2003, 34, 403-12. (Pubitemid 36935333)
87. A. Ewart-Toland, Q. Dai, Y. T. Gao, H. Nagase, M. G. Dunlop, S. M. Farrington, R. A. Barnetson, H. Anton-Culver, D. Peel, A. Ziogas, D. Lin, X. Miao, T. Sun, E. A. Ostrander, J. L. Stanford, M. Langlois, J. M. Chan, J. Yuan, C. C. Harris, E. D. Bowman, G. L. Clayman, S. M. Lippman, J. J. Lee, W. Zheng and A. Balmain, Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer types, Carcinogenesis, 2005, 26, 1368-73. (Pubitemid 41417879)
88. Y. G. Park, R. Clifford, K. H. Buetow and K. W. Hunter, Multiple cross and inbred strain haplotype mapping of complex-trait candidate genes, Genome Res., 2003, 13, 118-21.
89. X. Wang, R. Korstanje, D. Higgins and B. Paigen, Haplotype analysis in multiple crosses to identify a QTL gene, Genome Res., 2004, 14, 1767-72. (Pubitemid 39276435)
90. R. Hitzemann, B. Malmanger, S. Cooper, S. Coulombe, C. Reed, K. Demarest, J. Koyner, L. Cipp, J. Flint, C. Talbot, B. Rademacher, K. Buck and J. McCaughran, Jr., Multiple cross mapping (MCM) markedly improves the localization of a QTL for ethanol-induced activation, Genes Brain Behav., 2002, 1, 214-22.
91. R. Hitzemann, B. Malmanger, C. Reed, M. Lawler, B. Hitzemann, S. Coulombe, K. Buck, B. Rademacher, N. Walter, Y. Polyakov, J. Sikela, B. Gensler, S. Burgers, R. W. Williams, K. Manly, J. Flint and C. Talbot, A strategy for the integration of QTL, gene expression, and sequence analyses, Mamm. Genome, 2003, 14, 733-47. (Pubitemid 37363686)
92. B. Yalcin, S. A. Willis-Owen, J. Fullerton, A. Meesaq, R. M. Deacon, J. N. Rawlins, R. R. Copley, A. P. Morris, J. Flint and R. Mott, Genetic dissection of a behavioral quantitative trait locus shows that Rgs2 modulates anxiety in mice, Nat. Genet., 2004, 36, 1197-202. (Pubitemid 41288969)
93. R. Mott and J. Flint, Simultaneous detection and fine mapping of quantitative trait loci in mice using heterogeneous stocks, Genetics., 2002, 160, 1609-18. (Pubitemid 34454382)
94. R. Chia, F. Achilli, M. F. Festing and E. M. Fisher, The origins and uses of mouse outbred stocks, Nat. Genet., 2005, 37, 1181-6. (Pubitemid 41568697)
95. G. Manenti, F. Galbiati, R. Gianni-Barrera, A. Pettinicchio, A. Acevedo and T. A. Dragani, Haplotype sharing suggests that a genomic segment containing six genes accounts for the pulmonary adenoma susceptibility 1 (Pas1) locus activity in mice, Oncogene, 2004, 23, 4495-504.
96. H. Nagase, S. Bryson, H. Cordell, C. J. Kemp, F. Fee and A. Balmain, Distinct genetic loci control development of benign and malignant skin tumours in mice, Nat. Genet., 1995, 10, 424-9.
97. H. Nagase, J. H. Mao and A. Balmain, A subset of skin tumor modifier loci determines survival time of tumor-bearing mice, Proc. Natl. Acad. Sci. U. S. A., 1999, 96, 15032-7. (Pubitemid 30019760)
98. G. Manenti, F. Galbiati, S. Noci and T. A. Dragani, Outbred CD-1 mice carry the susceptibility allele at the pulmonary adenoma susceptibility 1 (Pas1) locus, Carcinogenesis, 2003, 24, 1143-8.
99. J. Flint, W. Valdar, S. Shifman and R. Mott, Strategies for mapping and cloning quantitative trait genes in rodents, Nat. Rev. Genet., 2005, 6, 271-86. (Pubitemid 40469047)
100. J. Flint, Mapping quantitative traits and strategies to find quantitative trait genes, Methods, 2010.
101. G. A. Churchill, D. C. Airey, H. Allayee, J. M. Angel, A. D. Attie, J. Beatty, W. D. Beavis and J. K. Belknap, The Collaborative Cross, a community resource for the genetic analysis of complex traits, Nat. Genet., 2004, 36, 1133-7.
102. F. A. Iraqi, G. Churchill and R. Mott, The Collaborative Cross, developing a resource for mammalian systems genetics: a status report of the Wellcome Trust cohort, Mamm. Genome, 2008, 19, 379-81.
103. A. Balmain, J. Gray and B. Ponder, The genetics and genomics of cancer, Nat. Genet., 2003, 33(Suppl), 238-44. (Pubitemid 36278834)
104. M. Arbilly, A. Pisante, M. Devor and A. Darvasi, An integrative approach for the identification of quantitative trait loci, Animal Genetics, 2006, 37(Suppl 1), 7-9. (Pubitemid 44091645)
105. R. C. Jansen and J. P. Nap, Genetical genomics: the added value from segregation, Trends Genet., 2001, 17, 388-91.
106. K. DiPetrillo, X. Wang, I. M. Stylianou and B. Paigen, Bioinformatics toolbox for narrowing rodent quantitative trait loci, Trends Genet., 2005, 21, 683-92. (Pubitemid 41608691)
107. E. S. Lander, L. M. Linton, B. Birren, C. Nusbaum, M. C. Zody, J. Baldwin, K. Devon and K. Dewar, et al., Initial sequencing and analysis of the human genome, Nature, 2001, 409, 860-921. (Pubitemid 32165345)
108. J. C. Venter, M. D. Adams, E. W. Myers, P. W. Li, R. J. Mural, G. G. Sutton, H. O. Smith and M. Yandell, et al., The sequence of the human genome, Science, 2001, 291, 1304-51. (Pubitemid 32173090)
109. R. H. Waterston, K. Lindblad-Toh, E. Birney, J. Rogers, J. F. Abril, P. Agarwal, R. Agarwala and R. Ainscough, et al., Initial sequencing and comparative analysis of the mouse genome, Nature, 2002, 420, 520-62. (Pubitemid 35477048)
110. The Chimpanzee Sequencing and Analysis Consortium, Initial sequence of the chimpanzee genome and comparison with the human genome, Nature, 2005, 437, 69-87.
111. K. Lindblad-Toh, C. M. Wade, T. S. Mikkelsen, E. K. Karlsson, D. B. Jaffe, M. Kamal, M. Clamp and J. L. Chang, et al., Genome sequence, comparative analysis and haplotype structure of the domestic dog, Nature, 2005, 438, 803-19.
112. K. A. Frazer, E. Eskin, H. M. Kang, M. A. Bogue, D. A. Hinds, E. J. Beilharz, R. V. Gupta, J. Montgomery, M. M. Morenzoni, G. B. Nilsen, C. L. Pethiyagoda, L. L. Stuve, F. M. Johnson, M. J. Daly, C. M. Wade and D. R. Cox, A sequence-based variation map of 8.27 million SNPs in inbred mouse strains, Nature, 2007, 448, 1050-3.
113. R. J. Klein, X. Xu, S. Mukherjee, J. Willis and J. Hayes, Successes of genome-wide association studies, Cell, 2010, 142, 350-1; author reply 353-5.
114. K. Wang, M. Bucan, S. F. Grant, G. Schellenberg and H. Hakonarson, Strategies for genetic studies of complex diseases, Cell, 2010, 142, 351-3; author reply 353-5.
115. B. W. Zanke, C. M. Greenwood, J. Rangrej, R. Kustra, A. Tenesa, S. M. Farrington, J. Prendergast, S. Olschwang, T. Chiang, E. Crowdy, V. Ferretti, P. Laflamme, S. Sundararajan, S. Roumy, J. F. Olivier, F. Robidoux, R. Sladek, A. Montpetit, P. Campbell, S. Bezieau, A. M. O'Shea, G. Zogopoulos, M. Cotterchio, P. Newcomb, J. McLaughlin, B. Younghusband, R. Green, J. Green, M. E. Porteous, H. Campbell, H. Blanche, M. Sahbatou, E. Tubacher, C. Bonaiti-Pellie, B. Buecher, E. Riboli, S. Kury, S. J. Chanock, J. Potter, G. Thomas, S. Gallinger, T. J. Hudson and M. G. Dunlop, Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24, Nat. Genet., 2007, 39, 989-94. (Pubitemid 47185183)
116. I. Tomlinson, E. Webb, L. Carvajal-Carmona, P. Broderick, Z. Kemp, S. Spain, S. Penegar, I. Chandler, M. Gorman, W. Wood, E. Barclay, S. Lubbe, L. Martin, G. Sellick, E. Jaeger, R. Hubner, R. Wild, A. Rowan, S. Fielding, K. Howarth, A. Silver, W. Atkin, K. Muir, R. Logan, D. Kerr, E. Johnstone, O. Sieber, R. Gray, H. Thomas, J. Peto, J. B. Cazier and R. Houlston, A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21, Nat. Genet., 2007, 39, 984-8. (Pubitemid 47185182)
117. K. A. Frazer, S. S. Murray, N. J. Schork and E. J. Topol, Human genetic variation and its contribution to complex traits, Nat. Rev. Genet., 2009, 10, 241-51.